In the Matter of Mosaic Nutriceuticals Corp.; Order of Suspension of Trading, 6051 [05-2264]

Download as PDF Federal Register / Vol. 70, No. 23 / Friday, February 4, 2005 / Notices [68 FR 17090] and finalizes the government-wide data standard. DATES: Comments must be submitted on or before March 7, 2005. Late comments will be considered to the extent practicable. Due to potential delays in OMB’s receipt and processing of mail sent through the U. S. Postal Service, we encourage respondents to submit comments electronically to ensure timely receipt. We cannot guarantee that comments mailed will be received before the comment closing date. Electronic mail comments may be submitted to: ahunt@omb.eop.gov. Please include ‘‘SF–424’’ in the subject line and the full body of your comments in the text of the electronic message (and as an attachment if you wish). Please include your name, title, organization, postal address, telephone number, and E-mail address in the text of the message. Comments may also be submitted via facsimile to 202–395– 7285. Comments may be mailed to Alexander Hunt, Office of Information and Regulatory Affairs, Office of Management and Budget, Room 10236, New Executive Office Building, 725 17th Street, NW., Washington, DC 20503. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Elizabeth Phillips, Office of Federal Financial Management, Office of Management and Budget, (202) 395– 3993. The standard forms can be downloaded from the OMB Grants Management home page (https:// www.whitehouse.gov/omb/grants). SUPPLEMENTARY INFORMATION A. Background OMB Control No.: 0348–0043. Title: Application for Federal Assistance. Form No.: SF–424. Type of Review: Extension of a currently approved collection. Respondents: States, Local Governments, non-profit organizations. Number of Responses: 100,000. Estimated Time Per Response: 20 minutes. Needs and Uses: The SF–424 is used to provide general information about the entity and the proposed project when applying for Federal assistance under grant and cooperative agreement awards. The Federal awarding agencies use information reported on this form for the pre-award and award processes. B. Public Comments and Responses Pursuant to the October 29, 2004, Federal Register notice, OMB received one comment letter relating to the proposed SF–424 information collection VerDate jul<14>2003 18:52 Feb 03, 2005 Jkt 205001 extension. The comment from a State government agency noted that the SF– 424 was not posted in a ‘‘fill-enabled and electronically saveable’’ format. We encourage use of the electronic application process under Grants.gov (https://www.grants.gov) where the SF– 424 is fill-enabled and electronically saveable. The form posted on OMB’s website is available in read-only ‘‘pdf’’ format. SECURITIES AND EXCHANGE COMMISSION David Zavada, Chief, Financial Standards and Grants Branch. [FR Doc. 05–2104 Filed 2–3–05; 8:45 am] 6051 January 31, 2005. BILLING CODE 3110–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] In the Matter of Mosaic Nutriceuticals Corp.; Order of Suspension of Trading February 2, 2005. It appears to the Securities and Exchange Commission that the public interest and the protection of investors require a suspension of trading in the securities of Mosaic Nutriceuticals Corp. (‘‘Mosaic’’). The Commission is concerned that Mosaic and/or certain of its shareholders may have unjustifiably relied on Rule 144(k) of the Securities Act of 1933 (‘‘Securities Act’’) in conducting an unlawful distribution of its securities that failed to comply with the resale restrictions of Rules 144 and 145 of the Securities Act. Mosaic, a company that has made no public filings with the Commission or the NASD, is quoted on the Pink Sheets under the ticker symbol MCNJ, and has been the subject of a spam e-mail touting the company’s shares. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above listed company. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the above listed company is suspended for the period from 9:30 a.m. e.s.t. February 2, 2005 through 11:59 p.m. e.s.t., on February 15, 2005. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 05–2264 Filed 2–2–05; 1:19 pm] BILLING CODE 8010–01–P PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 [Release No. 34–51107; File No. SR–CBOE– 2004–75] Self-Regulatory Organizations; Notice of Filing of Proposed Rule Change and Amendments No. 1 and 2 Thereto by the Chicago Board Options Exchange, Incorporated Relating to the Introduction of Remote Market-Makers Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 notice is hereby given that on November 22, 2004, the Chicago Board Options Exchange, Incorporated (‘‘CBOE’’ or ‘‘Exchange’’) filed with the Securities and Exchange Commission (‘‘Commission’’) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by CBOE. On January 10, 2005, CBOE filed Amendment No. 1 to the proposed rule change.3 On January 21, 2005, CBOE filed Amendment No. 2 to the proposed rule change.4 The Commission is publishing this notice to solicit comments on the proposed rule change, as amended, from interested persons. I. Self-Regulatory Organization’s Statement of the Terms of Substance of the Proposed Rule Change CBOE proposes to adopt rules authorizing remote market making. The text of the proposed rule change is available on the CBOE’s Web site (https://www.cboe.com), at the CBOE’s Office of the Secretary, and at the Commission’s Public Reference Room. II. Self-Regulatory Organization’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change In its filing with the Commission, the Exchange included statements concerning the purpose of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. The Exchange has prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements. 1 15 U.S.C. 78s(b)(1). CFR 240.19b–4. 3 Amendment No. 1 replaces and supercedes CBOE’s original 19b–4 filing in its entirety. 4 Amendment No. 2 replaces and supercedes CBOE’s original 19b–4 filing and Amendment No. 1 in their entirety. 2 17 E:\FR\FM\04FEN1.SGM 04FEN1

Agencies

[Federal Register Volume 70, Number 23 (Friday, February 4, 2005)]
[Notices]
[Page 6051]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2264]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Mosaic Nutriceuticals Corp.; Order of Suspension 
of Trading

February 2, 2005.
    It appears to the Securities and Exchange Commission that the 
public interest and the protection of investors require a suspension of 
trading in the securities of Mosaic Nutriceuticals Corp. (``Mosaic''). 
The Commission is concerned that Mosaic and/or certain of its 
shareholders may have unjustifiably relied on Rule 144(k) of the 
Securities Act of 1933 (``Securities Act'') in conducting an unlawful 
distribution of its securities that failed to comply with the resale 
restrictions of Rules 144 and 145 of the Securities Act. Mosaic, a 
company that has made no public filings with the Commission or the 
NASD, is quoted on the Pink Sheets under the ticker symbol MCNJ, and 
has been the subject of a spam e-mail touting the company's shares.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the above listed 
company is suspended for the period from 9:30 a.m. e.s.t. February 2, 
2005 through 11:59 p.m. e.s.t., on February 15, 2005.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 05-2264 Filed 2-2-05; 1:19 pm]
BILLING CODE 8010-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.